Poly Medicure Limited — Others, 15-05-2025: Monitoring Agency Report

Poly Medicure Limited has announced a board meeting on the financial results for the quarter and half-year. Crisil Ratings confirmed no deviations in the use of Rs 985.34 Cr raised via QIP, primarily for manufacturing facilities, inorganic growth, and corporate purposes. This quarter, Rs 107.40 Cr was utilized for general corporate needs, including Rs 22.40 Cr for working capital, while Rs 877.94 Cr remains unutilized in mutual funds and fixed deposits. Investment in manufacturing setups and acquisitions is in progress, with related spending expected in upcoming quarters.